Recent News

Upcoming Seminars and Events

View upcoming seminars and events.

Learn more
567 News Items found
micrograph of a T cell
Successfully Treated AML Patients May Hold the Key to New CAR T Cell Therapy

A team of researchers from MSK has developed a new type of CAR T cell therapy that shows promise against acute myeloid leukemia (AML) in preclinical models.
Caleb Lareau
Dr. Caleb Lareau Awarded 2026 Pershing Square Sohn Cancer Prize

MSK's Dr. Caleb Lareau was awarded a 2026 Pershing Square Sohn Cancer Prize, which is designed to empower early-career investigators to pursue bold, high-impact projects.
A researcher working in an MSK lab
MSK Research Highlights, April 27, 2026

New MSK research shows how pancreatic cancer cells organize themselves to fuel tumor growth; finds an antibody-drug conjugate shows efficacy in rare pediatric sarcoma; develops an AI tool could accelerate identification of disease-causing genetic variants; and builds quantum nanosensors for cancer blood tests.
a lab coat hangs in an MSK lab
Drs. Anna-Katerina Hadjantonakis and Robert Farese Elected to the American Academy of Arts and Sciences

Drs. Anna-Katerina Hadjantonakis and Robert Farese were elected to the 2026 class of the American Academy of Arts and Sciences.
Charles Sawyers presents at AACR 2026
AACR 2026 Research Roundup: The Latest Cancer Science Advances From MSK

Dozens of clinicians and scientists from across MSK presented the latest advances in cancer research at the 2026 American Association for Cancer Research (AACR) Annual Meeting, held April 17 to 22 in San Diego.
colorful microscope image of cancer cells
Catching Cancer’s Earliest Moments: How Mutated Cells Transform Their Local Environment So a Tumor Can Develop

MSK scientists are shedding new light on a tumor’s earliest moments — revealing how lung cells with cancer-causing mutations recruit accomplices from healthy surrounding tissue to pave the way for a tumor to develop.
Scott Lowe and Dana Pe'er
From Benign Growth to Pancreatic Cancer: New Study Shows How the Switch Gets Flipped

An MSK study reveals new details about how pancreatic cells carrying oncogenic mutations transition from benign to malignant — shining new light on the ecosystems that supports emerging tumors.
Christopher Lima
Dr. Christopher Lima Elected AAAS Fellow

Sloan Kettering Institute Structural Biology Program Chair Dr. Christopher Lima was elected to the 2025 class of American Association for the Advancement of Science Fellows.
Scott Lowe
Cell Surface Protein uPAR May Hold the Key to Targeting Solid Tumors with CAR T Cell Therapy

MSK researchers and collaborators have developed a new type of CAR T cell designed to attack a cell surface protein called uPAR — allowing them to target both tumors and cancer-supporting cells in the tumor microenvironment.
Microscope in foreground, MSK researchers in the background.
MSK Research Highlights, March 27, 2026

New MSK research finds skin stem cells retain long-lasting memory of inflammation; shows how a large cancer DNA study could transform personalized oncology; reveals how the protein BAF helps cancer cells hide from the immune system; and investigates how early DNA markings shape cell fate.